Section 12-6A-06 - Protocols(a) A protocol under this subtitle: (1) May authorize: (i) For protocols by a licensed physician and licensed pharmacist, the initiation of drug therapy under written, disease-state specific protocols;(ii) The modification, continuation, and discontinuation of drug therapy under written, disease-state specific protocols;(iii) The ordering of laboratory tests; and(iv) Other patient care management measures related to monitoring or improving the outcomes of drug or device therapy; and(2) May not authorize acts that exceed the scope of practice of the parties to the therapy management contract.(b) A protocol shall prohibit the substitution of a chemically dissimilar drug product by the pharmacist for the product prescribed by the authorized prescriber, unless permitted in the therapy management contract.Amended by 2015 Md. Laws, Ch. 269,Sec. 1, eff. 10/1/2015.